Conversion of Canatu Plc’s series C shares to series A shares

Canatu Plc Company Release 15 November 2024 at 9:00 am EET

Conversion of Canatu Plc’s series C shares to series A shares

Pursuant to Canatu Plc’s (the “Company”) articles of association, all outstanding series C shares will be automatically converted into series A shares at the end of the day 60 days after the entry into force of the articles of association at a 1:1 conversion rate.

The articles of association entered into force on 16 September 2024 and, therefore, all outstanding series C shares will be automatically converted into series A shares at the end of the day on 15 November 2024 at a 1:1 conversion rate. The number of shares to be converted is 21,791,821 series C shares.

As a result of the conversion of shares, the number of the Company’s series A shares is in total 33,336,816, the number of series B shares is in total 1,050,000 and the number of series C shares is in total 0. The conversion does not affect the total number of the Company’s shares or votes. The total number of shares and votes after the conversion is 34,386,816. Pursuant to the Company’s articles of association, no new series C shares may be issued after the conversion.

The conversion of shares will be registered in the Trade Register on 16 November 2024. The converted series A shares will be admitted to public trading on the Nasdaq First North Growth Market Finland marketplace together with the pre-existing series A shares as of 18 November 2024.

Additional information

Chair of the Board of Directors Timo Ahopelto, tel. +358 400 569 628

CEO Juha Kokkonen, tel. +358 405 430 367

Certified adviser

Carnegie Investment Bank AB (publ), tel. +46 (0)73 856 42 65

About Canatu

Canatu (CANATU, Nasdaq First North, Finland) is a fast-growing deep technology company creating advanced carbon nanotubes (Canatu CNTs), related products, and manufacturing equipment for the semiconductor, automotive, and medical diagnostics industries. Canatu partners with forerunner companies, together transforming products for better tomorrows with nano carbon.  

Canatu’s versatile platform technology has broad potential applications. Its current core includes CNT membranes for extreme ultraviolet (EUV) processes in the semiconductor industry, enabling the manufacturing of the most advanced chips, as well as film heaters for advanced driver-assistance systems (ADAS) in the automotive industry. Additionally, electrochemical sensors for medical diagnostics are in the development phase. Canatu’s patented CNT reactors and Dry Deposition^TM method yield clean and pristine CNTs. The company operates through two business models: selling CNT products directly, as well as selling CNT reactors and licensing the related technology so that customers can produce CNT products under a limited license.  

Headquartered in Finland, Canatu also operates in the US, Japan, and Taiwan. Founded in 2004 as a spin-off from Aalto University’s Nanomaterials Group, Canatu currently has around 130 employees representing over 30 nationalities, with 20 percent holding or pursuing doctorates. Discover more at www.canatu.com and follow us on LinkedIn.